These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Abrogation of skin disease in LUPUS-prone MRL/FASlpr mice by means of a novel tylophorine analog. Choi JY; Gao W; Odegard J; Shiah HS; Kashgarian M; McNiff JM; Baker DC; Cheng YC; Craft J Arthritis Rheum; 2006 Oct; 54(10):3277-83. PubMed ID: 17009262 [TBL] [Abstract][Full Text] [Related]
23. A soy diet accelerates renal damage in autoimmune MRL/Mp-lpr/lpr mice. Zhao JH; Sun SJ; Horiguchi H; Arao Y; Kanamori N; Kikuchi A; Oguma E; Kayama F Int Immunopharmacol; 2005 Oct; 5(11):1601-10. PubMed ID: 16039550 [TBL] [Abstract][Full Text] [Related]
24. IK cytokine ameliorates the progression of lupus nephritis in MRL/lpr mice. Muraoka M; Hasegawa H; Kohno M; Inoue A; Miyazaki T; Terada M; Nose M; Yasukawa M Arthritis Rheum; 2006 Nov; 54(11):3591-600. PubMed ID: 17075801 [TBL] [Abstract][Full Text] [Related]
25. Expression and response to angiotensin-converting enzyme inhibition of matrix metalloproteinases 2 and 9 in renal glomerular damage in young transgenic rats with renin-dependent hypertension. Bolbrinker J; Markovic S; Wehland M; Melenhorst WB; van Goor H; Kreutz R J Pharmacol Exp Ther; 2006 Jan; 316(1):8-16. PubMed ID: 16166267 [TBL] [Abstract][Full Text] [Related]
26. (5R)-5-hydroxytriptolide ameliorates lupus nephritis in MRL/ Zhang LY; Li H; Wu YW; Cheng L; Yan YX; Yang XQ; Zhu FH; He SJ; Tang W; Zuo JP Am J Physiol Renal Physiol; 2017 Apr; 312(4):F769-F777. PubMed ID: 28100505 [TBL] [Abstract][Full Text] [Related]
27. Therapeutic benefit of treatment with anti-thymocyte globulin and latent TGF-beta1 in the MRL/lpr lupus mouse model. Kaplan J; Woodworth L; Smith K; Coco J; Vitsky A; McPherson J Lupus; 2008 Sep; 17(9):822-31. PubMed ID: 18755864 [TBL] [Abstract][Full Text] [Related]
28. Fate of immune complexes, glomerulonephritis, and cell-mediated vasculitis in lupus-prone MRL/Mp lpr/lpr mice. Cruse JM; Lewis RE; Dilioglou S Exp Mol Pathol; 2000 Dec; 69(3):211-22. PubMed ID: 11115362 [TBL] [Abstract][Full Text] [Related]
29. Renoprotective effects of an angiotensin II receptor blocker in experimental model rats with hypertension and metabolic disorders. Watanabe D; Tanabe A; Naruse M; Morikawa S; Ezaki T; Takano K Hypertens Res; 2009 Sep; 32(9):807-15. PubMed ID: 19662019 [TBL] [Abstract][Full Text] [Related]
30. The effects of amlodipine and enalapril on renal function in adults with hypertension and nondiabetic nephropathies: a 3-year, randomized, multicenter, double-blind, placebo-controlled study. Esnault VL; Brown EA; Apetrei E; Bagon J; Calvo C; DeChatel R; Holdaas H; Krcmery S; Kobalava Z; Clin Ther; 2008 Mar; 30(3):482-98. PubMed ID: 18405787 [TBL] [Abstract][Full Text] [Related]
33. Immunosuppressive effects of (2R,5R)-6-heptyne-2,5-diamine, an inhibitor of polyamine synthesis: II. Beneficial effects on the development of a lupus-like disease in MRL-lpr/lpr mice. Claverie N; Pasquali JL; Mamont PS; Danzin C; Weil-Bousson M; Siat M Clin Exp Immunol; 1988 May; 72(2):293-8. PubMed ID: 3409547 [TBL] [Abstract][Full Text] [Related]
34. Inhibition of lupus disease by anti-double-stranded DNA antibodies of the IgM isotype in the (NZB x NZW)F1 mouse. Werwitzke S; Trick D; Kamino K; Matthias T; Kniesch K; Schlegelberger B; Schmidt RE; Witte T Arthritis Rheum; 2005 Nov; 52(11):3629-38. PubMed ID: 16255055 [TBL] [Abstract][Full Text] [Related]
35. Prevention and reversal of nephritis in MRL/lpr mice with a single injection of C-reactive protein. Rodriguez W; Mold C; Marnell LL; Hutt J; Silverman GJ; Tran D; Du Clos TW Arthritis Rheum; 2006 Jan; 54(1):325-35. PubMed ID: 16385552 [TBL] [Abstract][Full Text] [Related]
36. Glomerular Injury Is Exacerbated in Lupus-Prone MRL/lpr Mice Treated with a Protease-Activated Receptor 2 Antagonist. Itto R; Oe Y; Imaruoka K; Sato E; Sekimoto A; Yamakage S; Kumakura S; Sato H; Ito S; Takahashi N Tohoku J Exp Med; 2019 Oct; 249(2):127-133. PubMed ID: 31666446 [TBL] [Abstract][Full Text] [Related]
37. Expression and regulation of Toll-like receptors in lupus-like immune complex glomerulonephritis of MRL-Fas(lpr) mice. Patole PS; Pawar RD; Lech M; Zecher D; Schmidt H; Segerer S; Ellwart A; Henger A; Kretzler M; Anders HJ Nephrol Dial Transplant; 2006 Nov; 21(11):3062-73. PubMed ID: 16954173 [TBL] [Abstract][Full Text] [Related]
38. The ethyl acetate extract of alfalfa sprout ameliorates disease severity of autoimmune-prone MRL-lpr/lpr mice. Hong YH; Huang CJ; Wang SC; Lin BF Lupus; 2009 Mar; 18(3):206-15. PubMed ID: 19213858 [TBL] [Abstract][Full Text] [Related]
39. Amelioration of systemic lupus erythematosus by Withangulatin A in MRL/lpr mice. Sun L; Zhou L; Chen M; Zhong R; Liu J J Cell Biochem; 2011 Sep; 112(9):2376-82. PubMed ID: 21520246 [TBL] [Abstract][Full Text] [Related]
40. Losartan ameliorates progression of glomerular structural changes in diabetic KKAy mice. Sasaki M; Uehara S; Ohta H; Taguchi K; Kemi M; Nishikibe M; Matsumoto H Life Sci; 2004 Jul; 75(7):869-80. PubMed ID: 15183078 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]